Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The trypanosomiases.

Michael P Barrett1, Richard J S Burchmore, August Stich

  • 1Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building, University of Glasgow, G12 8QQ, Glasgow, UK. m.barrett@bio.gla.ac.uk

Lancet (London, England)
|November 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cell surface transporter mediates phenanthridine resistance in African trypanosomes.

npj antimicrobials and resistance·2026
Same author

Beyond resistance: Emerging methods to dissect drug responses in Leishmania.

PLoS pathogens·2026
Same author

Multi-drug tolerance in Leishmania persister-like cells.

Communications biology·2026
Same author

Rapid detection and quantification of glyphosate in water using a handheld portable biosensor.

Scientific reports·2026
Same author

Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum.

Nature communications·2026
Same author

A rare complication in humans of a rare disease in Germany: a case of bilateral tubo-ovarian abscesses caused by Brucella melitensis.

Infection·2026
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Trypanosomiases, including sleeping sickness and Chagas

Area of Science:

  • Parasitology
  • Tropical Medicine
  • Molecular Biology

Background:

  • Trypanosomiases are significant human and animal diseases caused by Trypanosoma parasites.
  • Human African trypanosomiasis (sleeping sickness) resurged in sub-Saharan Africa, while Chagas' disease remains prevalent in the Americas.
  • Both diseases are transmitted by arthropod vectors.

Purpose of the Study:

  • To review the current status of trypanosomiases, focusing on challenges in disease control and treatment.
  • To highlight the potential for new drug development targeting unique trypanosome biochemistry.
  • To emphasize the need for increased recognition and funding for these neglected diseases.

Main Methods:

  • Review of existing literature on trypanosomiases, vector control, and chemotherapy.

Related Experiment Videos

  • Analysis of trypanosome biology and host-parasite interactions.
  • Discussion of challenges and opportunities in drug discovery and disease management.

    • Main Results:

    • Insect vector control is a viable strategy for disease containment.
    • Current chemotherapies are suboptimal, necessitating the development of new drugs.
    • Trypanosomes possess unique biochemical features that present potential drug targets.

    Conclusions:

    • Despite challenges, integrated strategies involving vector control and improved chemotherapy offer hope for managing trypanosomiases.
    • Targeting unique trypanosome biochemistry could lead to more effective treatments.
    • Increased global recognition and funding are crucial for advancing control efforts against these neglected tropical diseases.